Literature DB >> 10580800

Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes.

R R Luedtke1, S A Griffin, S S Conroy, X Jin, A Pinto, S R Sesack.   

Abstract

The two D1-like dopamine receptor subtypes, D1a and D1b, are structurally similar and pharmacologically indistinguishable using currently available ligands. To differentiate between the D1-like dopamine receptor subtypes, murine monoclonal antibodies to the rat Dla and the rat D1b dopamine receptor have been prepared. Rat D1-like and D2-like dopamine receptors expressed in Sf9 cells were used to verify the immunospecificity of the monoclonal anti-(D1a dopamine receptor) and anti-(D1b dopamine receptor) antibodies using immunoblot and immunohistochemical techniques. These two antibodies were used to compare the temporal dynamics of D1-like dopamine receptors expressed in Sf9 cells following infection with recombinant baculovirus and to monitor the partial purification of detergent solubilized receptors following ion exchange chromatography. Immunoreactivity of the anti-(D1a receptor) antibody was observed in the striatum and cortical regions of the rat brain using immunoblot techniques. No reactivity on immunoblots was observed for the anti-(D1b receptor) antibody using rat brain tissue, probably due to the low levels of receptor expression. For immunohistochemical studies using rat brain slices, the anti-(D1a receptor) antibody heterogeneously labeled cells and punctate processes within the striatal neuropil while labeling in the adjacent cerebral cortex was weak. Anti-(D1b receptor) antibody immunoreactivity was weak in the .striatum and generally limited to sparse perikarya in the dorsal region. However, immunoreactivity was observed in numerous cells within the vertical and horizontal limbs of the diagonal band and in the ventral pallidum. Immunoreactivity of the anti-(D1b receptor) antibody was also observed in layer V pyramidal neurons of the frontal sensorimotor cortex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580800     DOI: 10.1016/s0165-5728(99)00142-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

1.  Dopamine receptors in the human dura mater.

Authors:  Carlo Cavallotti; Daniela Cavallotti; Gianfranco Tonnarini; Francesca Maria Tranquilli Leali
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

Review 2.  Fixation strategies for retinal immunohistochemistry.

Authors:  Tyler W Stradleigh; Andrew T Ishida
Journal:  Prog Retin Eye Res       Date:  2015-04-17       Impact factor: 21.198

3.  Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.

Authors:  Pamela J Voulalas; John Schetz; Ashiwel S Undieh
Journal:  Mol Cell Neurosci       Date:  2011-01-12       Impact factor: 4.314

4.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex.

Authors:  Melissa L Perreault; Jace Jones-Tabah; Brian F O'Dowd; Susan R George
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

6.  Extracellular dopamine, acetylcholine, and activation of dopamine D1 and D2 receptors after selective breeding for cocaine self-administration in rats.

Authors:  Haiyang Xu; Sasmita Das; Marc Sturgill; Colin Hodgkinson; Qiaoping Yuan; David Goldman; Kenneth Grasing
Journal:  Psychopharmacology (Berl)       Date:  2017-05-26       Impact factor: 4.530

7.  Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.

Authors:  Christopher H So; Vaneeta Verma; Mohammad Alijaniaram; Regina Cheng; Asim J Rashid; Brian F O'Dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

8.  Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.

Authors:  You He; Lei-Ping Yu; Guo-Zhang Jin
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

9.  Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades.

Authors:  Jun Chen; Milan Rusnak; Paul J Lombroso; Anita Sidhu
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

10.  Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development.

Authors:  Kiyomi Y Araki; John R Sims; Pradeep G Bhide
Journal:  Brain Res       Date:  2007-04-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.